Trials / Completed
CompletedNCT03485144
A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan
A Phase II Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Immunogenicity and Safety of TetraVax-DV in Healthy Adults in Taiwan
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Medigen Vaccine Biologics Corp. · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to determine the immunogenicity and safety of TV003(TetraVax-DV), a live attenuated tetravalent dengue vaccine candidate, in healthy human subjects in Taiwan
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | TV003 | Live attenuated virus vaccine-TetraVax-DV |
| BIOLOGICAL | Placebo for TV003 | Placebo |
Timeline
- Start date
- 2017-12-12
- Primary completion
- 2019-05-10
- Completion
- 2019-05-10
- First posted
- 2018-04-02
- Last updated
- 2019-08-14
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03485144. Inclusion in this directory is not an endorsement.